Literature DB >> 11557274

Senescent cells are resistant to death despite low Bcl-2 level.

M Sasaki1, T Kumazaki, H Takano, M Nishiyama, Y Mitsui.   

Abstract

Cellular senescence may be an antioncogenic event. Bcl-2 is a product of the oncogene, bcl-2, but it may also participate in cellular senescence. To investigate the role of Bcl-2, we analyzed the level of Bcl-2 during aging of normal human fibroblasts by immunoblot analysis and found that its level was highly suppressed in four normal senescent fibroblast strains. This result suggests that senescent cells are more sensitive to induction of death than young cells. Nevertheless, senescent cells showed more resistance to death induced by hydrogen peroxide than young cells, according to LDH assay. Because the balance among antiapoptotic and proapoptotic proteins is an important factor for the determination of cell death, we examined levels of other Bcl-2 family and apoptosis-regulating proteins, but observed no reasonable change to explain the resistance. During the course of the death induction experiment, we obtained results showing that growth-arrested cells were also resistant to death, and this was further confirmed by a BrdU-labeling experiment. As senescent cells are stopped permanently in the G0/G1-phase of the cell cycle, our data strongly suggest that this is the cause of resistance to death in senescent cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557274     DOI: 10.1016/s0047-6374(01)00281-0

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  23 in total

1.  Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.

Authors:  Liu Cao; Wenmei Li; Sangsoo Kim; Steven G Brodie; Chu-Xia Deng
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

2.  Establishment of human induced pluripotent stem cell lines from normal fibroblast TIG-1.

Authors:  Tsutomu Kumazaki; Sayaka Kurata; Taira Matsuo; Youji Mitsui; Tomoko Takahashi
Journal:  Hum Cell       Date:  2011-05-12       Impact factor: 4.174

3.  Apoptosis of hypothalamic neurosecretory cells in stress mice at different stages of ontogenesis.

Authors:  Yu V Abatnina; E D Bazhanova; D L Teplyi
Journal:  Neurosci Behav Physiol       Date:  2006-06

Review 4.  Strategies targeting cellular senescence.

Authors:  Yossi Ovadya; Valery Krizhanovsky
Journal:  J Clin Invest       Date:  2018-04-02       Impact factor: 14.808

5.  Differential regulation of the intrinsic pathway of apoptosis in brain and liver during ageing.

Authors:  Veronika Stoka; Vito Turk; Dale E Bredesen
Journal:  FEBS Lett       Date:  2006-06-09       Impact factor: 4.124

6.  Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer.

Authors:  M Ocker; D Neureiter; M Lueders; S Zopf; M Ganslmayer; E G Hahn; C Herold; D Schuppan
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

Review 7.  The impact of cellular senescence in cancer therapy: is it true or not?

Authors:  Yi Zhang; Jin-ming Yang
Journal:  Acta Pharmacol Sin       Date:  2011-09-12       Impact factor: 6.150

Review 8.  Therapy-induced senescence in cancer.

Authors:  Jonathan A Ewald; Joshua A Desotelle; George Wilding; David F Jarrard
Journal:  J Natl Cancer Inst       Date:  2010-09-21       Impact factor: 13.506

Review 9.  Memory T cells need CD28 costimulation to remember.

Authors:  Alina C Boesteanu; Peter D Katsikis
Journal:  Semin Immunol       Date:  2009-03-05       Impact factor: 11.130

10.  Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS.

Authors:  Tatyana A Klimova; Eric L Bell; Emelyn H Shroff; Frank D Weinberg; Colleen M Snyder; Goberdan P Dimri; Paul T Schumacker; G R Scott Budinger; Navdeep S Chandel
Journal:  FASEB J       Date:  2008-10-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.